why gout affects mainly at 1st metatarsalopharyngeal joint

Reading File

Finding Sources

Searching PubMed

gout AND "first metatarsophalangeal"

Searching the Web

gout first metatarsophalangeal joint predilection temperature biomechanics explanation

Gout commonly first attacks the 1st metatarsophalangeal (MTP) joint, the big-toe joint, causing podagra. It is a predilection, not an exclusive site.

Why this joint is favored:

Cooler peripheral temperature: Monosodium urate is less soluble at lower temperatures. The big toe is distal and relatively cool, especially overnight, so crystals precipitate more easily.
Mechanical stress and microtrauma: The 1st MTP bears high repetitive load and undergoes marked dorsiflexion during walking. Local physical stress can promote crystal nucleation and trigger inflammation.
Pre-existing osteoarthritis is common there: Damaged or osteoarthritic cartilage provides a favorable surface for urate crystal deposition. The big-toe MTP is a frequent site of osteoarthritis.
Local fluid and pH changes: Overnight dehydration, cooling, and changes in synovial fluid volume or acidity can transiently increase urate concentration and favor precipitation.
Crystal deposits are mechanically concentrated: Deposits tend to occur at the dorsal and medial parts of the 1st MTP, which are pressure-stressed during gait.

So, the classic location results from a combination of cold temperature + repeated trauma/loading + susceptible cartilage + local synovial conditions, not simply because serum uric acid is highest in the toe. Textbooks note that the 1st MTP is a classic focus, but gout can involve the ankle, midfoot, knee, wrist, fingers, and elbow as well. Review of podagra pathogenesis and a systematic review of the 1st MTP in gout describe this as multifactorial.

orotic aciduria can occur in ornithine transcarbomylase deficiency

Reading File

Finding Sources

Searching PubMed

ornithine transcarbamylase deficiency orotic aciduria

Searching the Web

ornithine transcarbamylase deficiency orotic aciduria mechanism carbamoyl phosphate pyrimidine synthesis

Yes. Ornithine transcarbamylase (OTC) deficiency causes orotic aciduria.

Mechanism:

OTC normally converts carbamoyl phosphate + ornithine → citrulline in mitochondria.
With OTC deficiency, carbamoyl phosphate accumulates in mitochondria.
Excess carbamoyl phosphate escapes into the cytosol.
It enters the pyrimidine synthesis pathway, leading to excess orotic acid formation and urinary excretion.

Typical findings in OTC deficiency:

Hyperammonemia
Increased urinary orotic acid
Low citrulline
Low arginine
Respiratory alkalosis early in acute hyperammonemia
X-linked inheritance

Important comparison:

Disorder	Ammonia	Orotic acid	Key point
OTC deficiency	High	High	Excess mitochondrial carbamoyl phosphate is diverted into pyrimidine synthesis
Carbamoyl phosphate synthetase I deficiency	High	Normal/low	Carbamoyl phosphate is not made, so none is diverted
UMP synthase deficiency	Normal	High	Causes megaloblastic anemia, but no hyperammonemia

what is orotic aciduria

Reading File

Finding Sources

Searching PubMed

orotic aciduria UMPS deficiency

Searching the Web

orotic aciduria UMP synthase deficiency clinical features treatment uridine

Orotic aciduria means an abnormally high amount of orotic acid in the urine. Orotic acid is an intermediate in the de novo pyrimidine synthesis pathway, used to make UMP and ultimately DNA/RNA nucleotides.

The term can refer to either a finding or a specific inherited disorder.

1. Hereditary orotic aciduria

This is a rare autosomal-recessive UMPS deficiency. UMP synthase normally converts orotic acid into UMP. When it is deficient:

Orotic acid accumulates and is excreted in urine
UMP and other pyrimidines are deficient
Features include megaloblastic anemia that does not respond to folate or vitamin B12, poor growth/failure to thrive, and developmental delay
Blood ammonia is normal
Treatment is uridine supplementation, which bypasses the metabolic block and reduces new orotic acid production

2. Orotic aciduria in OTC deficiency

Here, the primary problem is a urea-cycle defect, not UMPS deficiency:

OTC deficiency causes excess mitochondrial carbamoyl phosphate
It enters the cytosol and is diverted into pyrimidine synthesis
This produces excess orotic acid in urine
Unlike hereditary orotic aciduria, it produces hyperammonemia, often with low citrulline and low arginine

Feature	UMPS deficiency	OTC deficiency
Main pathway affected	Pyrimidine synthesis	Urea cycle
Blood ammonia	Normal	High
Megaloblastic anemia	Present	Not typical
Urinary orotic acid	High	High
Key mechanism	Cannot convert orotic acid to UMP	Excess carbamoyl phosphate drives orotic acid formation

Carries of tooth can be prevented by fluoride ions. Fluorosis.

Reading File

Finding Sources

Searching PubMed

fluoride dental caries fluorosis

Searching the Web

CDC fluoride prevents tooth decay dental fluorosis overview

Dental caries can be prevented by fluoride, but excess fluoride causes fluorosis. Thus, fluoride has a dose-dependent beneficial and harmful effect.

How fluoride prevents dental caries

Fluoride:

Incorporates into enamel to form fluorapatite, which is less soluble in acid than hydroxyapatite.
Promotes remineralization of early enamel lesions.
Reduces demineralization during bacterial acid attacks.
At higher local concentrations, inhibits bacterial metabolism and acid production.

Fluorosis

Fluorosis results from chronic excessive fluoride intake.

Dental fluorosis: occurs only while teeth are developing, mainly in children. It produces white streaks or flecks in mild cases, and brown staining, mottling, or enamel pitting in severe cases.
Skeletal fluorosis: prolonged high intake can cause increased bone density, bone/joint pain, stiffness, ligament calcification, and deformity.

A useful exam line:

Low fluoride intake predisposes to dental caries; optimum intake prevents caries; excessive chronic intake causes dental and skeletal fluorosis.

Dental fluorosis is not acquired after the enamel has formed, so it does not develop in adults from starting fluoride exposure. The CDC explanation of dental fluorosis notes that excess ingestion during tooth formation is responsible.

pyrimidine synthesis according to dm vasudevan

Reading File

Pyrimidine synthesis is usually studied under these headings:

De novo synthesis of pyrimidine nucleotides
- Formation of carbamoyl phosphate
- Carbamoyl aspartate → dihydroorotate → orotate
- Formation of OMP → UMP
- Conversion of UMP to UDP, UTP, CTP and dTMP
Salvage pathway
Regulation of pyrimidine synthesis
- Main regulatory enzyme: carbamoyl phosphate synthetase II (CPS-II)
- Activated by PRPP and ATP; inhibited by UTP
Synthesis of deoxypyrimidines
- Ribonucleotide reductase
- dUMP → dTMP by thymidylate synthase
- Role of folate and dihydrofolate reductase
Clinical correlations
- Hereditary orotic aciduria due to UMPS deficiency
- OTC deficiency causing secondary orotic aciduria
- Drug inhibitors: methotrexate, trimethoprim, 5-fluorouracil, hydroxyurea

Core distinction from purine synthesis:
In pyrimidine synthesis, the ring is made first and then attached to PRPP. In purine synthesis, the ring is built directly on PRPP.

Which format do you want for the detailed explanation?

Short exam note
Stepwise pathway with enzymes
Clinical correlations
MCQ-oriented revision

stepwise

Reading File

Finding Sources

Searching PubMed

pyrimidine synthesis metabolism

Searching the Web

pyrimidine biosynthesis pathway CPS II carbamoyl phosphate aspartate orotate UMP authoritative

De novo pyrimidine synthesis - stepwise

Main point: In pyrimidine synthesis, the ring is synthesized first and then attached to PRPP to form the nucleotide.

Site: Mainly cytosol.
Exception: conversion of dihydroorotate to orotate occurs in association with mitochondria.

Overall sequence

Glutamine + CO₂ + ATP → Carbamoyl phosphate → Carbamoyl aspartate → Dihydroorotate → Orotate → OMP → UMP → UDP → UTP → CTP

Step 1: Formation of carbamoyl phosphate

[ \text{Glutamine + CO₂ + 2 ATP} \rightarrow \text{Carbamoyl phosphate} ]

Enzyme: Carbamoyl phosphate synthetase II (CPS-II)
Location: Cytosol
Nitrogen donor: Glutamine
This is the committed and rate-limiting step of de novo pyrimidine synthesis.

Regulation

Activated by: PRPP and ATP
Inhibited by: UTP

CPS-II is different from CPS-I of the urea cycle. CPS-I is mitochondrial, uses free ammonia, and requires N-acetylglutamate. CPS-II is cytosolic and uses glutamine.

Step 2: Formation of carbamoyl aspartate

[ \text{Carbamoyl phosphate + Aspartate} \rightarrow \text{Carbamoyl aspartate} ]

Enzyme: Aspartate transcarbamoylase (ATCase)
Aspartate supplies atoms that become part of the pyrimidine ring.

Step 3: Formation of dihydroorotate

[ \text{Carbamoyl aspartate} \rightarrow \text{Dihydroorotate} ]

Enzyme: Dihydroorotase
This step closes the pyrimidine ring.

Step 4: Formation of orotic acid (orotate)

[ \text{Dihydroorotate} \rightarrow \text{Orotate} ]

Enzyme: Dihydroorotate dehydrogenase
Location: Mitochondrial inner membrane in humans
Coenzyme: FMN, with electrons transferred ultimately to coenzyme Q.

At this point, the pyrimidine ring is complete.

Step 5: Formation of OMP

[ \text{Orotate + PRPP} \rightarrow \text{Orotidine monophosphate (OMP)} ]

Enzyme: Orotate phosphoribosyltransferase
PRPP supplies the ribose-phosphate group.

Step 6: Formation of UMP

[ \text{OMP} \rightarrow \text{UMP + CO₂} ]

Enzyme: OMP decarboxylase

Steps 5 and 6 are catalyzed by the bifunctional enzyme UMP synthase (UMPS).

Formation of other pyrimidine nucleotides

UMP to UDP and UTP

[ \text{UMP} \rightarrow \text{UDP} \rightarrow \text{UTP} ]

UMP kinase: UMP → UDP
Nucleoside diphosphate kinase: UDP → UTP

UTP to CTP

[ \text{UTP + Glutamine + ATP} \rightarrow \text{CTP} ]

Enzyme: CTP synthetase
Glutamine provides the amino group.

Formation of deoxythymidylate, dTMP

For DNA synthesis:

[ \text{UDP} \rightarrow \text{dUDP} \rightarrow \text{dUMP} \rightarrow \text{dTMP} ]

UDP → dUDP
- Enzyme: Ribonucleotide reductase
- Converts ribonucleotides to deoxyribonucleotides.
- Inhibited by hydroxyurea.
dUMP → dTMP
- Enzyme: Thymidylate synthase
- Methyl donor: N⁵,N¹⁰-methylene tetrahydrofolate
- THF becomes dihydrofolate (DHF).
DHF → THF
- Enzyme: Dihydrofolate reductase (DHFR)
- Uses NADPH.
- Inhibited by methotrexate in humans and trimethoprim in bacteria.

5-fluorouracil inhibits thymidylate synthase, reducing dTMP and thereby DNA synthesis.

Important clinical correlation: hereditary orotic aciduria

Deficiency of UMP synthase causes:

[ \text{Orotate cannot become OMP and UMP} ]

Findings:

Increased urinary orotic acid
Megaloblastic anemia unresponsive to vitamin B12 or folate
Growth retardation/developmental problems
No hyperammonemia
Treatment: uridine

Differentiate from OTC deficiency

Feature	UMPS deficiency	OTC deficiency
Orotic acid in urine	Increased	Increased
Blood ammonia	Normal	Increased
Main defect	Pyrimidine synthesis	Urea cycle
Megaloblastic anemia	Present	Absent
Citrulline	Usually normal	Low

One-line memory sequence

CPS-II → ATCase → Dihydroorotase → Dihydroorotate dehydrogenase → OPRT → OMP decarboxylase

Or:

Carbamoyl phosphate → Carbamoyl aspartate → Dihydroorotate → Orotate → OMP → UMP

The first three enzymes in mammalian pyrimidine synthesis are part of the cytosolic multifunctional CAD protein, as described by NCBI's CAD gene entry.

On 17-year-old girl presented with fatigue, muscle weakness, and palp- polyurea urea. She had a history of kidney stones and bone pain. Laboratory investigations showed serum pH 7.32, bicarbonate 16 millimoles per liter, potassium is equal to 3.0 millimole per liter, chloride is equal to 110 millimoles per liter, and urine> 5.5. Urine anion gap was positive. What is the most probable diagnosis? Explain the biochemical basis of this condition.

Reading File

Finding Sources

Searching PubMed

distal renal tubular acidosis nephrolithiasis

Searching the Web

distal renal tubular acidosis urine pH positive urine anion gap hypokalemia nephrolithiasis pathophysiology

The most probable diagnosis is distal renal tubular acidosis (dRTA), Type 1 RTA.

Why this is Type 1 distal RTA

Finding	Interpretation
pH 7.32, HCO₃⁻ 16 mmol/L	Metabolic acidosis
Cl⁻ 110 mmol/L	Hyperchloremic, normal-anion-gap metabolic acidosis
K⁺ 3.0 mmol/L	Hypokalemia, causing muscle weakness and palpitations
Urine pH >5.5 despite systemic acidosis	Kidney cannot acidify urine: a distal acidification defect
Positive urine anion gap	Low urinary NH₄⁺ excretion, indicating inadequate renal acid excretion
Kidney stones, bone pain	Classic chronic complications of distal RTA

Biochemical basis

Normal distal nephron

In the collecting duct, alpha-intercalated cells secrete H⁺ into urine through:

H⁺-ATPase
H⁺/K⁺-ATPase

The secreted H⁺ is buffered by phosphate and ammonia, allowing acid to be excreted chiefly as NH₄⁺. Simultaneously, bicarbonate is returned to blood, maintaining acid-base balance.

In distal RTA

There is impaired H⁺ secretion in the distal nephron due to a defect in H⁺-ATPase, H⁺/K⁺-ATPase, chloride-bicarbonate exchange, or increased back-leak of H⁺.

Therefore:

[ \downarrow \text{H}^+ \text{ secretion} \rightarrow \downarrow \text{NH}_4^+ \text{ excretion} \rightarrow \text{metabolic acidosis} ]

Despite blood acidosis, urine remains inappropriately alkaline:

[ \text{Urine pH} > 5.5 ]

Why the urine anion gap is positive

[ \text{UAG} = (U_{Na^+} + U_{K^+}) - U_{Cl^-} ]

Normally during metabolic acidosis, the kidney increases NH₄⁺ excretion. NH₄⁺ is excreted with Cl⁻ as NH₄Cl, so urinary chloride rises and the UAG becomes negative.

In distal RTA, NH₄⁺ excretion is low. Urinary chloride does not rise adequately, so the UAG remains positive.

[ \text{Positive UAG} \Rightarrow \downarrow \text{NH}_4^+ \text{ excretion} \Rightarrow \text{renal cause of acidosis} ]

Why hypokalemia occurs

When distal H⁺ secretion is defective, renal Na⁺ reabsorption is accompanied relatively more by K⁺ secretion. Also, impaired H⁺/K⁺-ATPase activity reduces K⁺ reabsorption.

[ \downarrow \text{H}^+ \text{ secretion} \Rightarrow \uparrow \text{K}^+ \text{ loss in urine} \Rightarrow \text{hypokalemia} ]

Hypokalemia explains fatigue, muscle weakness, polyuria, and possible palpitations/arrhythmias.

Why renal stones and bone pain occur

Chronic acidosis causes:

Bone buffering of H⁺
- Bone mineral is mobilized, producing osteomalacia or bone pain.
- Calcium is released, causing hypercalciuria.
Hypocitraturia
- Acidosis increases proximal citrate reabsorption.
- Less urinary citrate is available to bind calcium.
- Citrate normally prevents calcium stone formation.
Alkaline urine
- Favors precipitation of calcium phosphate.

[ \text{Hypercalciuria} + \text{hypocitraturia} + \text{alkaline urine} \rightarrow \text{nephrocalcinosis and calcium phosphate renal stones} ]

Final diagnosis: Hypokalemic distal (Type 1) renal tubular acidosis with nephrolithiasis.

non alcoholic fatty liver disease

Reading File

Finding Sources

Searching PubMed

nonalcoholic fatty liver disease guideline

Searching the Web

2024 AASLD MASLD practice guidance diagnosis treatment fibrosis assessment

Non-alcoholic fatty liver disease (NAFLD) is the older term for excess fat accumulation in the liver in people without harmful alcohol intake. The preferred newer term is MASLD: metabolic dysfunction-associated steatotic liver disease.

It is strongly associated with obesity, insulin resistance/type 2 diabetes, dyslipidemia, and metabolic syndrome. It ranges from simple steatosis to steatohepatitis, fibrosis, cirrhosis, and occasionally hepatocellular carcinoma. Current practice emphasizes assessing fibrosis risk, because fibrosis predicts long-term liver outcomes.

Which aspect do you want to study?

Asking for Preferences

Choose the format/topic you need.

Gout commonly first attacks the 1st metatarsophalangeal (MTP) joint, the big-toe joint, causing podagra. It is a predilection, not an exclusive site.

Why this joint is favored:

Cooler peripheral temperature: Monosodium urate is less soluble at lower temperatures. The big toe is distal and relatively cool, especially overnight, so crystals precipitate more easily.
Mechanical stress and microtrauma: The 1st MTP bears high repetitive load and undergoes marked dorsiflexion during walking. Local physical stress can promote crystal nucleation and trigger inflammation.
Pre-existing osteoarthritis is common there: Damaged or osteoarthritic cartilage provides a favorable surface for urate crystal deposition. The big-toe MTP is a frequent site of osteoarthritis.
Local fluid and pH changes: Overnight dehydration, cooling, and changes in synovial fluid volume or acidity can transiently increase urate concentration and favor precipitation.
Crystal deposits are mechanically concentrated: Deposits tend to occur at the dorsal and medial parts of the 1st MTP, which are pressure-stressed during gait.

Mechanism:

OTC normally converts carbamoyl phosphate + ornithine → citrulline in mitochondria.
With OTC deficiency, carbamoyl phosphate accumulates in mitochondria.
Excess carbamoyl phosphate escapes into the cytosol.
It enters the pyrimidine synthesis pathway, leading to excess orotic acid formation and urinary excretion.

Typical findings in OTC deficiency:

Hyperammonemia
Increased urinary orotic acid
Low citrulline
Low arginine
Respiratory alkalosis early in acute hyperammonemia
X-linked inheritance

Important comparison:

Disorder	Ammonia	Orotic acid	Key point
OTC deficiency	High	High	Excess mitochondrial carbamoyl phosphate is diverted into pyrimidine synthesis
Carbamoyl phosphate synthetase I deficiency	High	Normal/low	Carbamoyl phosphate is not made, so none is diverted
UMP synthase deficiency	Normal	High	Causes megaloblastic anemia, but no hyperammonemia

Harrison's notes that among proximal urea-cycle defects, urinary orotic acid is increased specifically in OTC deficiency. NCBI urea-cycle overview explains the cytosolic diversion of carbamoyl phosphate.Orotic aciduria means an abnormally high amount of orotic acid in the urine. Orotic acid is an intermediate in the de novo pyrimidine synthesis pathway, used to make UMP and ultimately DNA/RNA nucleotides.

The term can refer to either a finding or a specific inherited disorder.

1. Hereditary orotic aciduria

This is a rare autosomal-recessive UMPS deficiency. UMP synthase normally converts orotic acid into UMP. When it is deficient:

Orotic acid accumulates and is excreted in urine
UMP and other pyrimidines are deficient
Features include megaloblastic anemia that does not respond to folate or vitamin B12, poor growth/failure to thrive, and developmental delay
Blood ammonia is normal
Treatment is uridine supplementation, which bypasses the metabolic block and reduces new orotic acid production

2. Orotic aciduria in OTC deficiency

Here, the primary problem is a urea-cycle defect, not UMPS deficiency:

OTC deficiency causes excess mitochondrial carbamoyl phosphate
It enters the cytosol and is diverted into pyrimidine synthesis
This produces excess orotic acid in urine
Unlike hereditary orotic aciduria, it produces hyperammonemia, often with low citrulline and low arginine

Feature	UMPS deficiency	OTC deficiency
Main pathway affected	Pyrimidine synthesis	Urea cycle
Blood ammonia	Normal	High
Megaloblastic anemia	Present	Not typical
Urinary orotic acid	High	High
Key mechanism	Cannot convert orotic acid to UMP	Excess carbamoyl phosphate drives orotic acid formation

So, orotic aciduria is not itself a diagnosis. It is a biochemical sign whose clinical meaning depends especially on whether ammonia is high. NCBI's overview of hereditary orotic aciduria identifies it as UMPS deficiency, whereas NCBI's urea-cycle review explains why OTC deficiency also raises urinary orotic acid.Dental caries can be prevented by fluoride, but excess fluoride causes fluorosis. Thus, fluoride has a dose-dependent beneficial and harmful effect.

How fluoride prevents dental caries

Fluoride:

Incorporates into enamel to form fluorapatite, which is less soluble in acid than hydroxyapatite.
Promotes remineralization of early enamel lesions.
Reduces demineralization during bacterial acid attacks.
At higher local concentrations, inhibits bacterial metabolism and acid production.

Fluorosis

Fluorosis results from chronic excessive fluoride intake.

Dental fluorosis: occurs only while teeth are developing, mainly in children. It produces white streaks or flecks in mild cases, and brown staining, mottling, or enamel pitting in severe cases.
Skeletal fluorosis: prolonged high intake can cause increased bone density, bone/joint pain, stiffness, ligament calcification, and deformity.

A useful exam line:

Low fluoride intake predisposes to dental caries; optimum intake prevents caries; excessive chronic intake causes dental and skeletal fluorosis.

De novo synthesis of pyrimidine nucleotides
- Formation of carbamoyl phosphate
- Carbamoyl aspartate → dihydroorotate → orotate
- Formation of OMP → UMP
- Conversion of UMP to UDP, UTP, CTP and dTMP
Salvage pathway
Regulation of pyrimidine synthesis
- Main regulatory enzyme: carbamoyl phosphate synthetase II (CPS-II)
- Activated by PRPP and ATP; inhibited by UTP
Synthesis of deoxypyrimidines
- Ribonucleotide reductase
- dUMP → dTMP by thymidylate synthase
- Role of folate and dihydrofolate reductase
Clinical correlations
- Hereditary orotic aciduria due to UMPS deficiency
- OTC deficiency causing secondary orotic aciduria
- Drug inhibitors: methotrexate, trimethoprim, 5-fluorouracil, hydroxyurea

Core distinction from purine synthesis:
In pyrimidine synthesis, the ring is made first and then attached to PRPP. In purine synthesis, the ring is built directly on PRPP.

Which format do you want for the detailed explanation?

Short exam note
Stepwise pathway with enzymes
Clinical correlations
MCQ-oriented revision## De novo pyrimidine synthesis - stepwise

Main point: In pyrimidine synthesis, the ring is synthesized first and then attached to PRPP to form the nucleotide.

Site: Mainly cytosol.
Exception: conversion of dihydroorotate to orotate occurs in association with mitochondria.

Overall sequence

Glutamine + CO₂ + ATP → Carbamoyl phosphate → Carbamoyl aspartate → Dihydroorotate → Orotate → OMP → UMP → UDP → UTP → CTP

Step 1: Formation of carbamoyl phosphate

[ \text{Glutamine + CO₂ + 2 ATP} \rightarrow \text{Carbamoyl phosphate} ]

Enzyme: Carbamoyl phosphate synthetase II (CPS-II)
Location: Cytosol
Nitrogen donor: Glutamine
This is the committed and rate-limiting step of de novo pyrimidine synthesis.

Regulation

Activated by: PRPP and ATP
Inhibited by: UTP

CPS-II is different from CPS-I of the urea cycle. CPS-I is mitochondrial, uses free ammonia, and requires N-acetylglutamate. CPS-II is cytosolic and uses glutamine.

Step 2: Formation of carbamoyl aspartate

[ \text{Carbamoyl phosphate + Aspartate} \rightarrow \text{Carbamoyl aspartate} ]

Enzyme: Aspartate transcarbamoylase (ATCase)
Aspartate supplies atoms that become part of the pyrimidine ring.

Step 3: Formation of dihydroorotate

[ \text{Carbamoyl aspartate} \rightarrow \text{Dihydroorotate} ]

Enzyme: Dihydroorotase
This step closes the pyrimidine ring.

Step 4: Formation of orotic acid (orotate)

[ \text{Dihydroorotate} \rightarrow \text{Orotate} ]

Enzyme: Dihydroorotate dehydrogenase
Location: Mitochondrial inner membrane in humans
Coenzyme: FMN, with electrons transferred ultimately to coenzyme Q.

At this point, the pyrimidine ring is complete.

Step 5: Formation of OMP

[ \text{Orotate + PRPP} \rightarrow \text{Orotidine monophosphate (OMP)} ]

Enzyme: Orotate phosphoribosyltransferase
PRPP supplies the ribose-phosphate group.

Step 6: Formation of UMP

[ \text{OMP} \rightarrow \text{UMP + CO₂} ]

Enzyme: OMP decarboxylase

Steps 5 and 6 are catalyzed by the bifunctional enzyme UMP synthase (UMPS).

Formation of other pyrimidine nucleotides

UMP to UDP and UTP

[ \text{UMP} \rightarrow \text{UDP} \rightarrow \text{UTP} ]

UMP kinase: UMP → UDP
Nucleoside diphosphate kinase: UDP → UTP

UTP to CTP

[ \text{UTP + Glutamine + ATP} \rightarrow \text{CTP} ]

Enzyme: CTP synthetase
Glutamine provides the amino group.

Formation of deoxythymidylate, dTMP

For DNA synthesis:

[ \text{UDP} \rightarrow \text{dUDP} \rightarrow \text{dUMP} \rightarrow \text{dTMP} ]

UDP → dUDP
- Enzyme: Ribonucleotide reductase
- Converts ribonucleotides to deoxyribonucleotides.
- Inhibited by hydroxyurea.
dUMP → dTMP
- Enzyme: Thymidylate synthase
- Methyl donor: N⁵,N¹⁰-methylene tetrahydrofolate
- THF becomes dihydrofolate (DHF).
DHF → THF
- Enzyme: Dihydrofolate reductase (DHFR)
- Uses NADPH.
- Inhibited by methotrexate in humans and trimethoprim in bacteria.

5-fluorouracil inhibits thymidylate synthase, reducing dTMP and thereby DNA synthesis.

Important clinical correlation: hereditary orotic aciduria

Deficiency of UMP synthase causes:

[ \text{Orotate cannot become OMP and UMP} ]

Findings:

Increased urinary orotic acid
Megaloblastic anemia unresponsive to vitamin B12 or folate
Growth retardation/developmental problems
No hyperammonemia
Treatment: uridine

Differentiate from OTC deficiency

Feature	UMPS deficiency	OTC deficiency
Orotic acid in urine	Increased	Increased
Blood ammonia	Normal	Increased
Main defect	Pyrimidine synthesis	Urea cycle
Megaloblastic anemia	Present	Absent
Citrulline	Usually normal	Low

One-line memory sequence

CPS-II → ATCase → Dihydroorotase → Dihydroorotate dehydrogenase → OPRT → OMP decarboxylase

Or:

Carbamoyl phosphate → Carbamoyl aspartate → Dihydroorotate → Orotate → OMP → UMP

The first three enzymes in mammalian pyrimidine synthesis are part of the cytosolic multifunctional CAD protein, as described by NCBI's CAD gene entry.The most probable diagnosis is distal renal tubular acidosis (dRTA), Type 1 RTA.

Why this is Type 1 distal RTA

Finding	Interpretation
pH 7.32, HCO₃⁻ 16 mmol/L	Metabolic acidosis
Cl⁻ 110 mmol/L	Hyperchloremic, normal-anion-gap metabolic acidosis
K⁺ 3.0 mmol/L	Hypokalemia, causing muscle weakness and palpitations
Urine pH >5.5 despite systemic acidosis	Kidney cannot acidify urine: a distal acidification defect
Positive urine anion gap	Low urinary NH₄⁺ excretion, indicating inadequate renal acid excretion
Kidney stones, bone pain	Classic chronic complications of distal RTA

Biochemical basis

Normal distal nephron

In the collecting duct, alpha-intercalated cells secrete H⁺ into urine through:

H⁺-ATPase
H⁺/K⁺-ATPase

The secreted H⁺ is buffered by phosphate and ammonia, allowing acid to be excreted chiefly as NH₄⁺. Simultaneously, bicarbonate is returned to blood, maintaining acid-base balance.

In distal RTA

There is impaired H⁺ secretion in the distal nephron due to a defect in H⁺-ATPase, H⁺/K⁺-ATPase, chloride-bicarbonate exchange, or increased back-leak of H⁺.

Therefore:

[ \downarrow \text{H}^+ \text{ secretion} \rightarrow \downarrow \text{NH}_4^+ \text{ excretion} \rightarrow \text{metabolic acidosis} ]

Despite blood acidosis, urine remains inappropriately alkaline:

[ \text{Urine pH} > 5.5 ]

Why the urine anion gap is positive

[ \text{UAG} = (U_{Na^+} + U_{K^+}) - U_{Cl^-} ]

Normally during metabolic acidosis, the kidney increases NH₄⁺ excretion. NH₄⁺ is excreted with Cl⁻ as NH₄Cl, so urinary chloride rises and the UAG becomes negative.

In distal RTA, NH₄⁺ excretion is low. Urinary chloride does not rise adequately, so the UAG remains positive.

[ \text{Positive UAG} \Rightarrow \downarrow \text{NH}_4^+ \text{ excretion} \Rightarrow \text{renal cause of acidosis} ]

Why hypokalemia occurs

When distal H⁺ secretion is defective, renal Na⁺ reabsorption is accompanied relatively more by K⁺ secretion. Also, impaired H⁺/K⁺-ATPase activity reduces K⁺ reabsorption.

[ \downarrow \text{H}^+ \text{ secretion} \Rightarrow \uparrow \text{K}^+ \text{ loss in urine} \Rightarrow \text{hypokalemia} ]

Hypokalemia explains fatigue, muscle weakness, polyuria, and possible palpitations/arrhythmias.

Why renal stones and bone pain occur

Chronic acidosis causes:

Bone buffering of H⁺
- Bone mineral is mobilized, producing osteomalacia or bone pain.
- Calcium is released, causing hypercalciuria.
Hypocitraturia
- Acidosis increases proximal citrate reabsorption.
- Less urinary citrate is available to bind calcium.
- Citrate normally prevents calcium stone formation.
Alkaline urine
- Favors precipitation of calcium phosphate.

[ \text{Hypercalciuria} + \text{hypocitraturia} + \text{alkaline urine} \rightarrow \text{nephrocalcinosis and calcium phosphate renal stones} ]

**Final diagnosis: Hypokalemic distal (Type 1) renal tubular acidosis with nephrolithiasis.**Non-alcoholic fatty liver disease (NAFLD) is the older term for excess fat accumulation in the liver in people without harmful alcohol intake. The preferred newer term is MASLD: metabolic dysfunction-associated steatotic liver disease.

Which aspect do you want to study?Please choose what you want for NAFLD/MASLD:

Short exam note
Biochemical pathogenesis
Diagnosis and tests
Management
Full topic map

Explain the biochemical pathogenesis of NAFLD

Reading File

Finding Sources

Searching PubMed

MASLD pathogenesis insulin resistance lipotoxicity

Searching the Web

MASLD NAFLD pathogenesis insulin resistance de novo lipogenesis lipotoxicity fibrosis review

Reading File

Biochemical pathogenesis of NAFLD

NAFLD is now more often termed MASLD (metabolic dysfunction-associated steatotic liver disease). It results from excessive triglyceride accumulation in hepatocytes, usually due to obesity and insulin resistance. Progression to inflammation and fibrosis is called NASH, now MASH.

Basic sequence

[ \text{Insulin resistance + excess calories} \rightarrow \text{increased hepatic fatty acids} \rightarrow \text{triglyceride accumulation (steatosis)} \rightarrow \text{lipotoxicity and oxidative stress} \rightarrow \text{inflammation and hepatocyte injury} \rightarrow \text{stellate-cell activation} \rightarrow \text{fibrosis/cirrhosis} ]

1. Insulin resistance causes increased fatty-acid delivery to liver

Normally insulin inhibits hormone-sensitive lipase in adipose tissue. In insulin resistance:

[ \downarrow \text{insulin action} \rightarrow \uparrow \text{adipose lipolysis} \rightarrow \uparrow \text{free fatty acids (FFA) in blood} \rightarrow \uparrow \text{FFA uptake by liver} ]

The liver converts surplus fatty acids into triglycerides (TAG) and stores them within hepatocytes as fat droplets.

Adipose tissue also produces less adiponectin, an insulin-sensitizing adipokine. Low adiponectin reduces fatty-acid oxidation and promotes lipid accumulation in liver.

2. Increased de novo lipogenesis

High carbohydrate and fructose intake, hyperinsulinemia, and hyperglycemia stimulate formation of fatty acids in the liver:

[ \text{Glucose} \rightarrow \text{Acetyl-CoA} \rightarrow \text{Fatty acids} \rightarrow \text{Triglycerides} ]

Important transcription factors:

SREBP-1c: stimulated by insulin
ChREBP: stimulated by glucose/fructose metabolites

These increase expression of enzymes such as:

Acetyl-CoA carboxylase
Fatty acid synthase

Thus, even though peripheral tissues are insulin resistant, hepatic lipogenesis may continue to be stimulated by high insulin levels.

3. Reduced fatty-acid disposal worsens steatosis

Normally hepatic fatty acids can be:

Oxidized in mitochondria by beta-oxidation
Converted to triglycerides and exported as VLDL
Stored as triglyceride

In NAFLD, fatty-acid delivery and synthesis exceed oxidation and VLDL export:

[ \text{FFA input + lipogenesis} > \text{beta-oxidation + VLDL export} ]

So, triglycerides accumulate in hepatocytes, producing macrovesicular steatosis.

4. Lipotoxicity converts simple steatosis to steatohepatitis

Triglyceride storage itself is relatively less harmful than accumulation of toxic lipid intermediates, such as:

Free fatty acids
Diacylglycerols
Ceramides
Free cholesterol

These cause lipotoxicity, leading to:

Mitochondrial dysfunction
Increased reactive oxygen species (ROS)
Lipid peroxidation
Endoplasmic-reticulum stress
Impaired ATP production
Hepatocyte apoptosis, necrosis, and ballooning degeneration

[ \text{Toxic lipid species} \rightarrow \text{ROS + ER stress + mitochondrial injury} \rightarrow \text{hepatocyte injury} ]

5. Inflammation

Damaged hepatocytes and toxic lipid products activate:

Kupffer cells, the resident macrophages of liver
Inflammasomes, especially the NLRP3 inflammasome
Inflammatory cytokines, including TNF-alpha, IL-6, and IL-1 beta

This produces hepatic inflammation and progression from isolated fatty liver to steatohepatitis.

6. Gut-liver axis

Obesity and altered intestinal microbiota may increase gut permeability. Bacterial endotoxin, particularly lipopolysaccharide, reaches the liver through portal blood and activates Kupffer cells.

[ \text{Gut dysbiosis} + \uparrow \text{intestinal permeability} \rightarrow \uparrow \text{portal endotoxin} \rightarrow \text{Kupffer-cell activation} \rightarrow \text{hepatic inflammation} ]

7. Fibrosis

Persistent hepatocyte injury and inflammation activate hepatic stellate cells. Activated stellate cells transform into myofibroblast-like cells and produce collagen.

[ \text{Hepatocyte injury/inflammation} \rightarrow \text{stellate-cell activation} \rightarrow \uparrow \text{collagen deposition} \rightarrow \text{fibrosis} \rightarrow \text{cirrhosis} ]

Fibrosis often begins in the perisinusoidal/pericellular zone 3 region. Advanced disease may progress to cirrhosis and hepatocellular carcinoma.

Exam summary

NAFLD develops primarily due to insulin resistance. It increases release of free fatty acids from adipose tissue and hepatic de novo lipogenesis, causing triglyceride accumulation in hepatocytes. Toxic lipid intermediates then produce oxidative stress, mitochondrial and ER dysfunction, inflammation, and hepatocyte injury. Chronic injury activates hepatic stellate cells, leading to collagen deposition and fibrosis.

Robbins describes obesity and insulin resistance as the initiating events, followed by increased free-fatty-acid flux, reduced adiponectin, lipotoxic injury, inflammasome activation, gut-derived endotoxin effects, stellate-cell activation, and fibrosis. Robbins & Kumar Basic Pathology, p. 612.

causes of nafld

Reading File

Finding Sources

Searching PubMed

MASLD risk factors

Searching the Web

MASLD risk factors obesity diabetes dyslipidemia genetic causes official guidance

Causes and risk factors of NAFLD

NAFLD, now commonly called MASLD, is mainly caused by metabolic dysfunction and insulin resistance. It is not due to significant alcohol intake.

Major causes/risk factors

Obesity, especially central or visceral obesity
- The most important risk factor.
- Increases free-fatty-acid delivery to liver.
Insulin resistance and type 2 diabetes mellitus
- Increases adipose lipolysis and hepatic fat synthesis.
- Diabetes also increases risk of steatohepatitis and fibrosis.
Metabolic syndrome
- Abdominal obesity
- Hyperglycemia/diabetes
- Hypertriglyceridemia
- Low HDL cholesterol
- Hypertension
Dyslipidemia
- Especially high triglycerides and low HDL.
Diet and lifestyle
- Excess calorie intake
- High fructose/sugary beverages
- Refined carbohydrate-rich diet
- Saturated fat-rich diet
- Physical inactivity
Genetic predisposition
- Variants in PNPLA3, TM6SF2, MBOAT7, and GCKR genes can increase susceptibility.
- Explains NAFLD in some lean individuals.
Endocrine and associated conditions
- Polycystic ovary syndrome
- Hypothyroidism
- Obstructive sleep apnea
- Hypopituitarism/growth hormone deficiency
- Chronic kidney disease
Medications causing secondary fatty liver
- Corticosteroids
- Amiodarone
- Tamoxifen
- Methotrexate
- Valproate
- Some antiretroviral drugs

Exam answer

NAFLD is chiefly associated with obesity, insulin resistance, type 2 diabetes mellitus, dyslipidemia, hypertension, and metabolic syndrome. High-calorie diets, fructose intake, sedentary lifestyle, genetic susceptibility, endocrine disorders, and certain drugs contribute to hepatic triglyceride accumulation.

Important: Before diagnosing NAFLD/MASLD, clinicians should exclude other causes of steatosis, particularly significant alcohol intake, viral hepatitis, hepatotoxic drugs, and inherited metabolic liver disease. Robbins & Kumar Basic Pathology, p. 611-612.

mitochondrial dna short answer according to dm vasudevan book

Reading File

Finding Sources

Searching PubMed

mitochondrial DNA inheritance

Searching the Web

mitochondrial DNA 16,569 base pairs 37 genes maternal inheritance NIH

Finding Sources

Mitochondrial DNA (mtDNA) - short answer

Mitochondria contain their own circular, double-stranded DNA, supporting the endosymbiotic origin of mitochondria.

Human mtDNA is 16,569 base pairs long.
Each mitochondrion contains several copies of mtDNA; each cell therefore contains many copies.
mtDNA contains 37 genes:
- 13 polypeptides of oxidative phosphorylation complexes
- 22 tRNAs
- 2 rRNAs: 12S and 16S rRNA
Most mitochondrial proteins are encoded by nuclear DNA, synthesized in cytoplasm, and imported into mitochondria.
mtDNA is maternally inherited, because sperm mitochondria are normally not transmitted to the zygote.
It has no histones, very few non-coding sequences/introns, and a high mutation rate due to limited DNA repair and exposure to reactive oxygen species.
Mutations can show heteroplasmy, meaning normal and mutant mtDNA coexist in the same cell.
Disease severity depends on the proportion of mutant mtDNA, known as the threshold effect.
mtDNA mutations particularly affect tissues with high ATP demand, such as brain, skeletal muscle, heart, retina, and kidney.

Examples of mitochondrial diseases: MELAS, MERRF, Leber hereditary optic neuropathy, and Kearns-Sayre syndrome.

Note: I could not verify the exact wording from D. M. Vasudevan because that specific book is not available in the provided library. The facts above are standard medical-biochemistry content.

.Describe the separation of serum proteins by paper electrophoresis

Reading File

Finding Sources

Searching PubMed

serum protein electrophoresis

Searching the Web

serum protein electrophoresis albumin alpha 1 alpha 2 beta gamma alkaline pH principle

Searching Images

serum protein electrophoresis normal pattern albumin alpha1 alpha2 beta gamma diagram

Separation of serum proteins by paper electrophoresis

Principle: At alkaline pH, serum proteins carry a net negative charge and migrate towards the anode in an electric field. Their separation depends mainly on their net charge and, to a lesser extent, size and shape.

Procedure

A strip of filter paper is soaked in alkaline buffer, usually barbital buffer of pH 8.6.
A small spot of serum is applied near the cathodal end of the paper.
The paper is placed with its ends in buffer reservoirs connected to electrodes.
On applying electric current, negatively charged proteins move towards the anode.
After migration, the paper is dried and stained using a protein stain such as Amido black or Ponceau S.
The separated bands are assessed visually or quantitatively by densitometry.

Normal electrophoretic pattern

At pH 8.6, the order of migration from anode to cathode is:

[ \boxed{\text{Albumin} \rightarrow \alpha_1 \rightarrow \alpha_2 \rightarrow \beta \rightarrow \gamma} ]

Fraction	Major proteins
Albumin	Albumin, fastest-moving and largest band
Alpha-1 globulin	Alpha-1 antitrypsin, alpha-1 acid glycoprotein
Alpha-2 globulin	Haptoglobin, ceruloplasmin, alpha-2 macroglobulin
Beta globulin	Transferrin, beta-lipoprotein, complement C3
Gamma globulin	Mainly immunoglobulins: IgG, IgA, IgM

Schematic representation

Anode (+)                                            Cathode (-)

Albumin     α1        α2          β              γ
  ████      █         ██          ██            ███
fastest                                           slowest

Albumin migrates fastest because it has the greatest net negative charge at alkaline pH. Gamma globulins migrate least.

Important points

Serum, not plasma, should be used. Plasma contains fibrinogen, which forms an extra band in the beta-gamma region.
It is useful in detecting:
- Monoclonal gammopathy/multiple myeloma: narrow M band or M spike in gamma region
- Chronic liver disease: beta-gamma bridging
- Nephrotic syndrome: low albumin, raised alpha-2 globulin
- Acute inflammation: raised alpha-1 and alpha-2 globulins

The recognized serum fractions at pH 8.6 are albumin, alpha-1, alpha-2, beta, and gamma globulins, as summarized in the NCBI electrophoresis reference table.

trick to remember etc

Reading File

Easy trick for serum protein electrophoresis

Order from anode (+) to cathode (-):

[ \boxed{\text{Albumin} \rightarrow \alpha_1 \rightarrow \alpha_2 \rightarrow \beta \rightarrow \gamma} ]

Mnemonic

“A Alpha Alpha Beta Gamma”
“All Ants Are Big Guys”

All = Albumin
Ants = α1
Are = α2
Big = β
Guys = γ

Direction trick

“Albumin runs Ahead”

Albumin is most negatively charged at pH 8.6, so it moves fastest toward the anode.

ANODE (+)                                    CATHODE (-)
Albumin → α1 → α2 → β → γ
fastest                         slowest

Remember major proteins

Band	Trick	Main protein
Albumin	A = Albumin alone	Albumin
α1	A1AT	Alpha-1 antitrypsin
α2	HaCer Macro	Haptoglobin, Ceruloplasmin, alpha-2 macroglobulin
β	TBC	Transferrin, Beta-lipoprotein, Complement C3
γ	GAMMA = Globulins/antibodies	Immunoglobulins

One-line revision:

At alkaline pH, serum proteins are negative and move to anode: Albumin, alpha-1, alpha-2, beta, gamma.

trick to remember electron transport chain

Reading File

Finding Sources

Searching PubMed

electron transport chain complexes oxidative phosphorylation

Searching the Web

electron transport chain complexes I II III IV proton pumping Q cytochrome c authoritative

Easy tricks for Electron Transport Chain (ETC)

1. Order of complexes

[ \boxed{I \rightarrow II \rightarrow III \rightarrow IV \rightarrow V} ]

Mnemonic:

“I Intend To Take Vacation”

I = Complex I
II = Complex II
III = Complex III
IV = Complex IV
V = Complex V, ATP synthase

2. Names of complexes

Complex	Name	Trick
I	NADH dehydrogenase	I = NADH In
II	Succinate dehydrogenase	II = Succinate Starts here
III	Cytochrome bc₁ / CoQ-cytochrome c reductase	III = Q to c
IV	Cytochrome c oxidase	IV = Oxygen is at the end
V	ATP synthase	V = ATP factory

3. Electron flow

For NADH:

[ \boxed{\text{NADH} \rightarrow I \rightarrow Q \rightarrow III \rightarrow Cyt~c \rightarrow IV \rightarrow O_2} ]

Mnemonic:

“Naughty Indians Quit Class, Come Out”

Naughty = NADH
Indians = Complex I
Quit = Coenzyme Q
Class = Complex III
Come = Cytochrome c
Out = Oxygen

For FADH₂:

[ \boxed{\text{FADH}_2 \rightarrow II \rightarrow Q \rightarrow III \rightarrow Cyt~c \rightarrow IV \rightarrow O_2} ]

Key point:

NADH enters at I; FADH₂ enters at II.

4. Proton-pumping complexes

[ \boxed{\text{I, III, IV pump H}^+} ]

Mnemonic:

“I Carry IV bags”
I - III - IV pump protons.

Complex II does not pump protons.

5. Proton numbers

For each NADH:

[ \boxed{I = 4,\quad III = 4,\quad IV = 2} ]

Total = 10 H⁺ pumped

Mnemonic:

“4, 4, 2 - NADH pays the proton due.”

For FADH₂, it bypasses complex I:

[ \boxed{III = 4,\quad IV = 2 = 6H^+} ]

Thus:

NADH gives about 2.5 ATP
FADH₂ gives about 1.5 ATP

6. Mobile carriers

There are two mobile carriers:

Coenzyme Q (ubiquinone): transfers electrons from Complex I and II to III
Cytochrome c: transfers electrons from Complex III to IV

Mnemonic:

“Q goes before III; c goes after III.”

[ I/II \rightarrow Q \rightarrow III \rightarrow Cyt~c \rightarrow IV ]

7. Inhibitors

Inhibitor	Complex	Trick
Rotenone, amytal	I	Rota is No. 1
Malonate	II	Malonate mimics succinate
Antimycin A	III	A = after II, at III
Cyanide, carbon monoxide, azide	IV	C-C-A stop Complex IV
Oligomycin	V	Oligomycin obstructs ATP synthase

Mnemonic for Complex IV inhibitors:

“Cyanide, CO, Azide choke oxygen.”

Complex IV transfers electrons to oxygen, the final electron acceptor, forming water. NCBI's ETC overview confirms the sequence I, II, Q, III, cytochrome c, and IV.

A four year old girl was brought to the OPD for not being able to walk properly. O/E she had bowed legs, thick wrists and dental caries. Her weight (8 kgs) and height (72.5cm) were below third percentile for her age. X-Ray shows cupping and widening of metaphyseal end of bone, poor bone mineralization. • Lab investigations showed: Serum Calcium – 8.5 mg/dL, Serum phosphorous – 3.0 mg/dL, Serum Alkaline phosphatase – 924 U/L, Serum 25-OH Vitamin D – 12 ng /mL. a) What is your provisional diagnosis? b) Write the daily requirement and sources of the deficient nutrient in the above condition and its main functions. c) Write in detail about its deficiency manifestations in children and adults. d) What are the causes of this disease?

Reading File

Finding Sources

Searching PubMed

nutritional rickets vitamin D deficiency

Searching the Web

rickets vitamin D deficiency causes clinical features daily requirement sources children NIH fact sheet

Searching Images

radiograph nutritional vitamin D deficiency rickets metaphyseal cupping fraying widening wrist

a) Provisional diagnosis

Nutritional vitamin D deficiency rickets in a child, with probable associated calcium deficiency/protein-energy undernutrition.

Evidence

Bowed legs, widened wrists, short stature, delayed walking
X-ray: metaphyseal cupping and widening, poor mineralization
Low serum 25-OH vitamin D: 12 ng/mL
Raised alkaline phosphatase: 924 U/L, indicating increased osteoblastic activity
Low-normal calcium and low phosphate

Biochemical basis

Vitamin D is needed for intestinal absorption of calcium and phosphate and for proper mineralization of osteoid at the growing epiphysis.

[ \downarrow \text{Vitamin D} \rightarrow \downarrow \text{intestinal Ca}^{2+}\text{ and phosphate absorption} \rightarrow \uparrow \text{PTH} ]

PTH maintains serum calcium by increasing bone resorption and renal calcium reabsorption, but also increases renal phosphate loss.

[ \downarrow \text{phosphate} + \text{inadequate Ca}^{2+} \rightarrow \text{failure of mineralization at growth plates} \rightarrow \text{rickets} ]

The unmineralized osteoid and widened growth plates cause bone softness and deformities.

b) Vitamin D: daily requirement, sources, and functions

Daily requirement

For a healthy 4-year-old child:

[ \boxed{15 \ \mu g/day = 600 \ IU/day} ]

For infants, the usual recommendation is 400 IU/day.

Sources

Main source: sunlight

UVB rays convert 7-dehydrocholesterol in skin to cholecalciferol, vitamin D₃.

Dietary sources

Fish liver oils and fatty fish
Egg yolk
Liver
Butter and ghee
Milk and fortified dairy products
Fortified cereals and foods
Mushrooms, especially those exposed to UV light, provide vitamin D₂

Main functions

Increases intestinal absorption of calcium and phosphate.
Maintains serum calcium and phosphate concentrations.
Promotes mineralization of bone and teeth.
Facilitates normal bone growth and skeletal development.
Helps maintain neuromuscular function.
Along with PTH, participates in calcium homeostasis.

c) Deficiency manifestations

In children: Rickets

General features

Irritability, sweating, poor growth, failure to thrive
Delayed motor milestones and delayed walking
Muscle weakness and hypotonia
Bone pain

Skull

Craniotabes, soft skull bones
Frontal bossing
Delayed closure of fontanelle
Square-shaped head

Chest

Rachitic rosary: enlarged costochondral junctions
Harrison sulcus: groove at attachment of diaphragm
Pigeon chest

Limbs

Widened wrists and ankles due to metaphyseal enlargement
Bowed legs, genu varum, or knock-knees, genu valgum
Bone deformities and pathological fractures

Teeth

Delayed dentition
Enamel hypoplasia and increased risk of dental caries

Severe hypocalcemia

Tetany
Carpopedal spasm
Seizures
Laryngospasm

Radiology

Generalized osteopenia
Widening of growth plates
Metaphyseal cupping, fraying, and splaying, especially at wrist and knee

In adults: Osteomalacia

Since epiphyses are closed in adults, vitamin D deficiency causes osteomalacia, not rickets.

Diffuse bone pain, especially hips, pelvis, back, and legs
Proximal muscle weakness and waddling gait
Difficulty rising from a chair or climbing stairs
Fragility fractures or pseudofractures, Looser zones
Reduced bone mineral density
Hypocalcemia may cause tetany in severe cases

The NIH vitamin D fact sheet notes that deficiency causes rickets in children and osteomalacia in adolescents and adults.

d) Causes of vitamin D deficiency rickets

1. Nutritional causes

Inadequate dietary vitamin D
Inadequate calcium intake
Prolonged exclusive breast-feeding without vitamin D supplementation
Maternal vitamin D deficiency
Protein-energy malnutrition
Diet lacking fortified milk, eggs, fish, or other vitamin D sources

2. Inadequate sun exposure

Indoor lifestyle
Covering clothing
High latitude/winter season
Air pollution
Dark skin pigmentation
Excessive sunscreen use

3. Malabsorption of vitamin D

Celiac disease
Chronic diarrhea
Cystic fibrosis
Cholestatic liver disease and reduced bile salt availability
Pancreatic insufficiency
Short bowel syndrome

4. Impaired activation of vitamin D

Chronic liver disease: reduced 25-hydroxylation
Chronic kidney disease: reduced 1-alpha hydroxylation to calcitriol

5. Increased vitamin D breakdown

Anticonvulsants, especially phenytoin and phenobarbital
Rifampicin
Glucocorticoids

6. Genetic causes

Vitamin D-dependent rickets type 1: deficiency of renal 1-alpha hydroxylase
Vitamin D-dependent rickets type 2: vitamin D receptor resistance
Hereditary hypophosphatemic rickets, such as X-linked hypophosphatemia

One-line exam conclusion

This child has nutritional vitamin D deficiency rickets, caused by inadequate vitamin D leading to reduced calcium and phosphate absorption, secondary hyperparathyroidism, hypophosphatemia, and defective mineralization of growing bone.

. A person is recovering from massive haemorrhage. How would this affect TCA cycle? Discuss with reference to the Anaplerotic role of citric acid cycle.

Reading File

Finding Sources

Searching PubMed

citric acid cycle anaplerosis erythropoiesis heme synthesis

Searching the Web

anaplerotic reactions TCA cycle heme synthesis succinyl CoA erythropoiesis physiology

During recovery from massive hemorrhage, erythropoiesis increases in bone marrow to replace lost red blood cells. This greatly increases hemoglobin synthesis, especially heme synthesis.

Effect on TCA cycle

Heme synthesis requires succinyl-CoA, a TCA-cycle intermediate.

[ \text{Succinyl-CoA + glycine} \xrightarrow[\text{PLP}]{\text{ALA synthase}} \delta\text{-aminolevulinate (ALA)} \rightarrow \text{heme} ]

Thus, increased heme production withdraws succinyl-CoA from the TCA cycle. Withdrawal of a TCA intermediate for biosynthesis is called cataplerosis.

[ \text{Increased erythropoiesis} \rightarrow \uparrow \text{heme synthesis} \rightarrow \uparrow \text{use of succinyl-CoA} \rightarrow \downarrow \text{TCA-cycle intermediates} ]

If not corrected, the cycle slows, causing reduced formation of NADH/FADH₂ and reduced ATP generation.

Anaplerotic role of the TCA cycle

Anaplerotic reactions are reactions that replenish TCA-cycle intermediates removed for biosynthesis.

The main anaplerotic reaction is:

[ \text{Pyruvate + CO}_2 + ATP \xrightarrow[\text{Biotin}]{\text{Pyruvate carboxylase}} \text{Oxaloacetate} ]

Oxaloacetate then enters the TCA cycle and permits continued production of intermediates, including succinyl-CoA.

Other replenishing pathways include:

Substrate	TCA intermediate formed
Pyruvate	Oxaloacetate
Aspartate by transamination	Oxaloacetate
Glutamate by transamination/deamination	Alpha-ketoglutarate
Propionyl-CoA from odd-chain fatty acids; valine, isoleucine, methionine, threonine	Succinyl-CoA

Conclusion

In recovery from massive hemorrhage, increased erythropoiesis demands increased heme synthesis. Heme synthesis withdraws succinyl-CoA from the TCA cycle. This cataplerotic loss is compensated by anaplerotic reactions, chiefly pyruvate carboxylase formation of oxaloacetate, thereby maintaining TCA-cycle activity and energy production.

Keywords for exam: hemorrhage → erythropoiesis → heme synthesis → succinyl-CoA utilization → cataplerosis → pyruvate carboxylase → oxaloacetate replenishment → anaplerosis.

This is a shared conversation. Sign in to Orris to start your own chat.